Medicine and Dentistry
Hepatocellular Carcinoma
100%
Surgery
61%
Liver Transplantation
40%
Cholangiocarcinoma
38%
Yttrium 90
26%
Disease
26%
Radioembolization
26%
Hepatic Portal Vein
25%
Nonalcoholic Fatty Liver
23%
Neoplasm
22%
Embolization
19%
Hepatectomy
19%
Microsphere
18%
Heart Arrest
17%
Liver Graft
15%
Graft Failure
14%
Recurrent Disease
13%
Overall Survival
13%
Liver Cirrhosis
12%
Response Evaluation Criteria in Solid Tumors
10%
Fibrosis
10%
Liver Disease
10%
Liver Fibrosis
9%
Liver Cancer
9%
Metastatic Carcinoma
9%
Liver Tumor
9%
Liver Failure
9%
Clostridium Difficile Infection
8%
Aortoiliac Disease
8%
General Surgery
8%
Stereotactic Body Radiation Therapy
8%
Hypothermia
8%
Efferocytosis
8%
Hyperbilirubinemia
8%
Arm
8%
Steatohepatitis
8%
Liver Cancer Prevention
8%
Kidney Transplantation
8%
Gene Expression Profiling
8%
Intracardiac Thrombosis
8%
Caroli Disease
8%
Cannulation
8%
Systematic Review
8%
Pancreas Transplantation
8%
Cava Vein Obstruction
8%
Endarterectomy
8%
Hepatitis
8%
Cemiplimab
8%
Squamous Cell Carcinoma
8%
Lysophosphatidic Acid
8%
Keyphrases
Hepatocellular Carcinoma
93%
Liver Transplantation
40%
Radioembolization
26%
Nonalcoholic Steatohepatitis
23%
Resection
22%
Liver
21%
Intrahepatic Cholangiocarcinoma (iCCA)
20%
Tumor
17%
Benchmark Values
17%
Portal Vein Embolization
17%
Yttrium-90
17%
Human Liver
17%
Single-center Experience
17%
Phase II Trial
17%
Expert Center
17%
Graft Failure
15%
Surgical Resection
15%
Confidence Interval
13%
Gallbladder Cancer
12%
Overall Survival
11%
Cirrhosis
11%
Hepatitis B Virus
11%
Imaging Response
10%
Unresectable Hepatocellular Carcinoma
10%
Surgical Treatment
10%
Liver Macrophages
10%
Surgical Management
10%
Access to Transplantation
10%
Liver Transplant Recipients
10%
Liver Tumor
10%
Perihilar Cholangiocarcinoma
10%
Oncological Outcomes
10%
Interleukin-1β
10%
Complete Response
10%
Fibrosis Progression
9%
Reperfusion
9%
Glass Based
9%
Initially Unresectable
9%
Surgical Outcomes
9%
Liver Resection
9%
Liver Failure
9%
Liver Cancer
8%
NLRP3 Pathway
8%
Stereotactic Body Radiation Therapy
8%
Multicentric
8%
Prolonged Cardiac Arrest
8%
Hepatobiliary Surgery
8%
Safety Response
8%
Efferocytosis
8%
Anti-hepatocellular Carcinoma
8%